Barbara B Bendlin Selected Research

Biomarkers (Surrogate Marker)

1/2024	Elevated CSF angiopoietin-2 correlates with blood-brain barrier leakiness and markers of neuronal injury in early Alzheimer's disease.
1/2024	CSF Biomarkers in Longitudinal Alzheimer Disease Cohorts: Pre-Analytic Challenges.
7/2023	Prevalence and Clinical Implications of a β-Amyloid-Negative, Tau-Positive Cerebrospinal Fluid Biomarker Profile in Alzheimer Disease.
5/2023	Large-scale proteome and metabolome analysis of CSF implicates altered glucose and carbon metabolism and succinylcarnitine in Alzheimer's disease.
1/2023	Impact of asthma on the brain: evidence from diffusion MRI, CSF biomarkers and cognitive decline.
1/2023	Neuropathology-based APOE genetic risk score better quantifies Alzheimer's risk.
1/2023	Comparing Symmetric Dimethylarginine and Amyloid-β42 as Predictors of Alzheimer's Disease Development.
1/2022	Crosswalk study on blood collection-tube types for Alzheimer's disease biomarkers.
1/2022	Inflammation, tau pathology, and synaptic integrity associated with sleep spindles and memory prior to β-amyloid positivity.
1/2022	Alzheimer's disease biomarkers in Black and non-Hispanic White cohorts: A contextualized review of the evidence.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Barbara B Bendlin Research Topics

Disease

60	Alzheimer Disease (Alzheimer's Disease) 01/2024 - 02/2009
27	Cognitive Dysfunction 01/2024 - 01/2010
16	Dementia (Dementias) 01/2024 - 04/2012
9	Type 2 Diabetes Mellitus (MODY) 01/2023 - 06/2016
9	Insulin Resistance 01/2023 - 02/2013
8	Atrophy 01/2021 - 01/2010
7	Inflammation (Inflammations) 11/2023 - 05/2014
6	Neuroinflammatory Diseases 01/2024 - 01/2016
5	Parkinson Disease (Parkinson's Disease) 01/2016 - 03/2011
3	Genetic Risk Score 01/2023 - 01/2017
3	Asthma (Bronchial Asthma) 01/2023 - 01/2022
3	Cardiovascular Diseases (Cardiovascular Disease) 03/2021 - 11/2018
2	Apnea 05/2024 - 01/2022
2	Amyloidosis 01/2022 - 12/2019
2	Abdominal Obesity 01/2019 - 07/2013
2	Cerebrovascular Disorders (Cerebrovascular Occlusion) 12/2018 - 11/2018
2	Amyloid Plaque 09/2015 - 05/2013
2	Neurodegenerative Diseases (Neurodegenerative Disease) 05/2012 - 01/2010
1	Disorders of Excessive Somnolence (Hypersomnia) 01/2024
1	Vitamin D Deficiency 01/2024
1	Disease Progression 07/2023
1	Genetic Predisposition to Disease (Genetic Predisposition) 01/2022
1	Neurobehavioral Manifestations 01/2021
1	Vascular Diseases (Vascular Disease) 01/2021
1	Diabetes Complications 01/2020
1	Hypertension (High Blood Pressure) 01/2019
1	Obesity 01/2019
1	Myocardial Infarction 11/2018
1	Sleep Apnea Syndromes (Sleep Apnea) 09/2015
1	Sleepiness 09/2015
1	Hyperglycemia 05/2015
1	Neoplasms (Cancer) 05/2014
1	Infections 05/2014
1	Dyslipidemias (Dyslipidemia) 01/2010

Drug/Important Bio-Agent (IBA)

47	Biomarkers (Surrogate Marker)IBA 01/2024 - 09/2011
39	Amyloid (Amyloid Fibrils)IBA 01/2024 - 05/2013
9	NeurograninIBA 01/2024 - 08/2017
9	ApolipoproteinsIBA 01/2023 - 02/2009
8	Apolipoproteins E (ApoE)IBA 01/2023 - 01/2010
7	Glucose (Dextrose)FDA LinkGeneric 05/2023 - 02/2013
6	Apolipoprotein E4IBA 10/2020 - 02/2009
5	Amyloid beta-PeptidesIBA 01/2024 - 01/2016
5	Proteins (Proteins, Gene)FDA Link 05/2023 - 05/2013
5	Insulin (Novolin)FDA Link 01/2020 - 05/2012
3	SynucleinsIBA 01/2024 - 01/2021
3	2- (4'- (methylamino)phenyl)- 6- hydroxybenzothiazole (Pittsburgh compound B)IBA 01/2023 - 03/2014
3	Chitinase-3-Like Protein 1IBA 01/2021 - 01/2016
3	HaptoglobinsIBA 01/2020 - 11/2017
3	Levodopa (L Dopa)FDA LinkGeneric 08/2014 - 09/2011
2	formic acid (formate)IBA 01/2024 - 09/2023
2	Interleukin-6 (Interleukin 6)IBA 01/2023 - 01/2021
2	trimethyloxamine (trimethylamine N-oxide)IBA 01/2022 - 12/2018
2	tau Proteins (tau Protein)IBA 01/2022 - 01/2017
2	Glial Fibrillary Acidic ProteinIBA 01/2021 - 05/2013
2	Indicators and Reagents (Reagents)IBA 01/2021 - 01/2014
2	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 08/2017 - 01/2016
2	3-tyrosineIBA 08/2014 - 09/2011
2	HDL CholesterolIBA 07/2013 - 01/2010
2	fluorodopa F 18IBA 09/2011 - 03/2011
1	Oxyhemoglobins (Oxyhemoglobin)IBA 05/2024
1	Angiopoietin-2IBA 01/2024
1	AD 20 (AD-20)IBA 01/2024
1	mutalipocin IIIBA 01/2024
1	Vitamin B 6IBA 01/2024
1	Leukocyte L1 Antigen Complex (Calgranulin)IBA 11/2023
1	CarbonIBA 05/2023
1	Amyloidogenic ProteinsIBA 05/2023
1	ProteomeIBA 05/2023
1	symmetric dimethylarginineIBA 01/2023
1	CytokinesIBA 01/2023
1	Edetic Acid (EDTA)FDA Link 01/2022
1	Heparin (Liquaemin)FDA LinkGeneric 01/2022
1	CholesterolIBA 01/2021
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2021
1	Calcium-Binding ProteinsIBA 01/2021
1	Starch SynthaseIBA 01/2020
1	Vitamin E FDA LinkGeneric 01/2020
1	salicylhydroxamic acid (SHAM)IBA 01/2020
1	Tumor Necrosis Factor Ligand Superfamily Member 14IBA 01/2019
1	Hypoglycemic Agents (Hypoglycemics)IBA 01/2019
1	Choline (Choline Chloride)IBA 12/2018
1	Poly TIBA 11/2017
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 05/2017
1	CatecholaminesIBA 08/2014
1	Acetyl Coenzyme A (Acetyl-CoA)IBA 05/2014
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 03/2014
1	Triglycerides (Triacylglycerol)IBA 07/2013
1	HomocysteineIBA 04/2012
1	Tolcapone (Tasmar)FDA Link 09/2011
1	Catechol O-Methyltransferase (Methyltransferase, Catechol)IBA 09/2011
1	Dopamine (Intropin)FDA LinkGeneric 09/2011
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2010

Therapy/Procedure

4	Therapeutics 11/2023 - 05/2017
2	Glycemic Control 11/2017 - 06/2016
1	Hyperbaric Oxygenation 01/2020
1	Caloric Restriction 04/2012